Tuesday 25 September 2018
Contact US    |    Archive
reuters
1 months ago

Amicus sets $315,000 price for new Fabry disease treatment

Amicus Therapeutics on Monday set an average price of $315,000 per year for its newly approved Fabry disease treatment, a price it believes is below that of the main existing treatment in the United States.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Amicus

 | 

sets

 | 

315

 | 

000

 | 

price

 | 

for

 | 

new

 | 

Fabry

 | 

disease

 | 

treatment

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Brownlow red carpet 2018

- theage.com.au

Most Popular (a week)